In this first study of its kind designed to assess the impact of RIC on inflammatory cytokines in participants admitted to hospital with COVID-19, we were unable to detect a significant reduction by RIC in levels of pro-inflammatory cytokines (including IL-1β, IL-6, and TNF-α). This evidence concerns the gene IL6 and COVID-19.